Journal of Nanomedicine & Biotherapeutic Discovery
Open Access

Nanotechnology for Revolutionizing Medical Imagining for Accurate and Precise Disease Detection

Robert Danney^{* *}Correspondence: Robert Danney, Department of Nanotechnology, University of Sydney, Sydney, Australia, Email:

Author info »

Description

In the scope of Medical diagnostics, technological advancements have made the way for more accurate and efficient methods of detecting and treating diseases. One such development has been the integration of nanotechnology into diagnostic imaging. By harnessing the power of nanoscale materials and devices, researchers and clinicians are revolutionizing the field of medical imaging, enabling us to delve deeper into the human body with unprecedented precision and clarity.

The power of nanotechnology

Nanotechnology operates at a scale of billionths of a meter, allowing for the manipulation and control of matter at the atomic and molecular level. This extraordinary level of precision has a lot of potential for diagnostic imaging, as it enables the development of imaging agents and devices that can interact with cells, tissues, and even individual molecules. By leveraging the unique properties of nanoparticles, such as their small size, large surface area, and customizable surface chemistry, researchers have unlocked new opportunities in medical imaging [1].

Enhanced contrast and sensitivity

One of the most significant advantages of nanotechnology based diagnostic imaging is the ability to enhance contrast and sensitivity. Traditional imaging techniques often struggle to differentiate between healthy and diseased tissues, leading to false positives or missed diagnoses. However, nanomaterials such as quantum dots and superparamagnetic nanoparticles, can be engineered to produce a stronger signal, thereby improving the accuracy and sensitivity of imaging modalities like Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET). These nanoparticles can selectively target specific cells or tissues, allowing for early disease detection and precise localization of abnormalities.

Targeted delivery systems

Nanotechnology also offers the potential for targeted delivery systems in diagnostic Imaging. By functionalizing nanoparticles with specific ligands or antibodies, they can be guided to specific sites in the body, homing in on areas of interest, such as tumor cells. This targeted approach minimizes the impact on healthy tissues, reducing side effects and improving patient outcomes. Furthermore, these nanoparticles can be designed to carry diagnostic agents or therapeutic payloads, enabling simultaneous imaging and treatment, a concept known as theranostics. This integration of diagnosis and therapy provides a lot of potential for personalized medicine and efficient healthcare delivery [2,3].

Real-time monitoring and early detection

Diagnostic imaging in nanotechnology has the potential to provide real-time monitoring of physiological processes and disease progression. For instance, Nano sensors can be embedded within tissues or organs to monitor various parameters, such as pH levels, oxygenation, or drug concentrations. This dynamic monitoring allows for timely interventions and adjustments in treatment plans. Additionally, nanoscale imaging agents can detect molecular changes associated with diseases at their earliest stages, enabling early detection and intervention. By identifying diseases at their developing Phases, healthcare providers can administer targeted therapies, potentially saving lives and reducing the burden of advanced disease management [4].

Challenges and ethical considerations

While the potential of diagnostic imaging in nanotechnology is immense, it is crucial to acknowledge the challenges and ethical considerations associated with its implementation [5]. Safety concerns regarding the long-term effects of nanoparticles in the human body must be thoroughly addressed through rigorous research and clinical trials. Additionally, the cost-effectiveness and accessibility of nanotechnology based diagnostic imaging should be considered to ensure equitable healthcare access for all [6].

Diagnostic imaging with nanotechnology

Recent years have witnessed a substantial gain in our knowledge of nanomaterials and our capacity to regulate and alter their physicochemical characteristics, which has resulted in a major improvement in customizing interactions at the material-biology interface [7]. Due to their distinctive optical, magnetic, or electrical capabilities at the nanoscale, inorganic nanoparticles have received the most attention and have been employed widely in imaging applications.

Magnetic Resonance Imaging (MRI) contrast agents: Nuclear Magnetic Resonance (NMR) is a technique for non-invasive clinical imaging that is frequently employed in MRI. Iron oxide nanoparticle based T2 contrast agents, which were formerly licensed for clinical use have been removed due to their poor clinical performance and limited utilization [8].

Contrast agents for computed tomography: A clinical imaging technique called CT (Computed Tomography) makes advantage of the X-ray's interaction with the body or a contrast agent. Since atomic number of a material and X-ray attenuation are connected, higher Z elements like Ba or I-based CT contrast agents are employed in clinical settings [9]. These contrast agents not only have poor contrast production at high voltages but also have difficulties with toxicity and quick elimination.

Optical imaging agents: Due to their excellent resolution and depth of tissue penetration for imaging purposes, whole body imaging techniques like MRI (Magnetic Resonance Imaging) and CT (Computed Tomography) have seen great clinical success. However, they also have drawbacks like a higher and longer dose of radiation exposure that restricts their applicability in real-time monitoring. Development of alternative methods, such as Fluorescence Lifetime Imaging Multiphoton (FLIM) Tomography, which combines time-correlated single photon imaging with ultrashort laser imaging [10].

Luminescent imaging agents that up convert: The Anti-Stokes emission mechanism is used by Up-Conversion Nanoparticles (UCNPs), another family of imaging agents, however unlike multiphoton absorption, photons are really absorbed through true electronic intermediate states, leading to improved efficiency and prolonged luminosity. In contrast to multiphoton excitation, which calls for a high-power pulsed laser, this enables quicker and more effective imaging utilizing Up-Converting Nanoparticles (UCNPs) with a low-power density laser and wide-field microscope [11].

Conclusion

Diagnostic imaging in nanotechnology represents a remarkable progress in medical diagnostics, offering unprecedented opportunities for accurate and efficient disease detection and treatment. By harnessing the unique properties of nanoparticles, researchers and clinicians are altering the healthcare landscape by providing strong tools to clinicians to help them decode the complexity of the human body. As this field continues to evolve, it is imperative that we strike a balance between scientific progress, patient safety, and ethical considerations to realize the full potential of diagnostic imaging in nanotechnology. The future of healthcare and nanotechnology is leading the way. With In vivo imaging and diagnostics, nanotechnology based technologies have advanced significantly in recent years, and great progress has been made towards their clinical translation. This accomplishment has been made possible by advancements in our understanding of nanoparticle characteristics and our capacity to customize them to create targeted, stimuli-responsive contrast agents with regulated attributes and bio distribution profiles.

References

1. Bellucci S, Chiaretti M, Onorato P, Rossella F, Grandi MS, Galinetto P, et al. Micro-Raman study of the role of sterilization on carbon nanotubes for biomedical applications. Nanomedicine. 2010;5(2):209-215.

   [Crossref] [Google Scholar] [PubMed]

2. Li W, Yi X, Liu X, Zhang Z, Fu Y, Gong T. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy. J Control Release. 2016;225:170–182.

   [Crossref] [Google Scholar] [PubMed]

3. Wang S, Xu T, Yang Y, Shao Z. Colloidal stability of silk fibroin nanoparticles coated with cationic polymer for effective drug delivery. ACS Appl Mater Interfaces. 2015;7(38):21254–21262.

   [Crossref] [Google Scholar] [PubMed]

4. Wright DM, Rickard JJ, Kyle N, Gard T, Dobberstein H, Motskin M, et al. The use of dual beam ESEM FIB to reveal the internal ultrastructure of hydroxyapatite nanoparticle-sugar-glass composites. J Mater Sci Med. 2009;20:203–214.

   [Crossref] [Google Scholar] [PubMed]

5. Tuan Ho S, Hutmacher DW. A comparison of micro CT with other techniques used in the characterization of scaffolds. Biomaterials. 2006;27:1362–1376.

   [Crossref] [Google Scholar] [PubMed]

6. Kang N, Perron M-E, Prud homme RE, Zhang Y, Gaucher G, Leroux J-C. Stereocomplex block copolymer micelles: core − shell nanostructures with enhanced stability. Nano Lett. 2005;5(2):315–319.

   [Crossref] [Google Scholar] [PubMed]

7. Shao Y, Zhang C, Yao Q, Wang Y, Tian B, Tang X, et al. Improving cabazitaxel chemical stability in parenteral lipid emulsions using cholesterol. Eur J Pharm Sci. 2014;52:1–11.

   [Crossref] [Google Scholar] [PubMed]

8. Min KH, Lee HJ, Kim K, Kwon IC, Jeong SY, Lee SC. The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles. Biomaterials. 2012;33(23):5788–5797.

   [Crossref] [Google Scholar] [PubMed]

9. Urabe K, Kato T, Stauss S, Himeno S, Kato S, Muneoka H, et al (2013) Dynamics of pulsed laser ablation in high-density carbon dioxide including supercritical fluid state. J Appl Phys 114:143303.

   [Crossref] [Google Scholar]

10. Yang L, May PW, Yin L, J.A. Smith, K.N. Rosser (2007) Growth of diamond nanocrystals by pulsed laser ablation of graphite in liquid. Diam Relat Mater 16:725–729.

    [Crossref] [Google Scholar]

11. Vlǎdoiu I, Stafe M, Neguţu C, Popescu IM (2008) Nanopulsed ablation rate of metals dependence on the laser fluence and wavelength in atmospheric air. UPB Sci Bull Ser A Appl Math Phys 70:119–126.

    [Google Scholar]